| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 50.755 | 118.588 | 103.926 | 75.874 | 69.090 | 3.763 | 30.972 | 3.098 | 20.570 | 8.731 |
| Total Income - EUR | 63.879 | 118.751 | 104.049 | 75.874 | 69.090 | 3.763 | 30.972 | 3.098 | 20.570 | 10.277 |
| Total Expenses - EUR | 52.650 | 106.196 | 93.844 | 63.572 | 58.191 | 12.373 | 34.506 | 6.206 | 22.801 | 12.551 |
| Gross Profit/Loss - EUR | 11.229 | 12.555 | 10.204 | 12.302 | 10.899 | -8.610 | -3.535 | -3.108 | -2.231 | -2.274 |
| Net Profit/Loss - EUR | 9.302 | 10.142 | 9.164 | 11.542 | 10.208 | -8.647 | -4.449 | -3.201 | -2.231 | -2.274 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Kemifarma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.342 | 13.918 | 13.554 | 13.180 | 12.843 | 12.564 | 12.250 | 12.253 | 12.181 | 12.081 |
| Current Assets | 76.659 | 150.918 | 85.215 | 66.832 | 59.121 | 46.481 | 43.809 | 37.858 | 35.605 | 33.634 |
| Inventories | 22.556 | 14.849 | 55.474 | 39.313 | 13.228 | 12.757 | 8.436 | 8.462 | 5.267 | 4.498 |
| Receivables | 29.215 | 58.589 | 22.419 | 20.556 | 17.839 | 11.958 | 12.369 | 7.731 | 7.417 | 8.022 |
| Cash | 24.888 | 77.480 | 7.323 | 4.525 | 28.054 | 21.766 | 23.004 | 21.666 | 22.922 | 21.114 |
| Shareholders Funds | 44.065 | 28.496 | 27.212 | 38.255 | 29.310 | 20.107 | 15.213 | 12.059 | 9.791 | 7.463 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 47.886 | 137.280 | 44.694 | 42.664 | 43.542 | 39.810 | 41.700 | 38.908 | 38.848 | 39.101 |
| Income in Advance | 0 | 59.722 | 31.811 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Kemifarma Srl